TruCBN™
Medicare BEI Program
About Us
Resources
TruCBN™
The Info Sheet
Concise overview of TruCBN™: clinical data, GLP safety package, dosing, formats, and regulatory status.
The Sleep Study
Peer-reviewed, placebo-controlled study in 1,020 adults showing 50 mg TruCBN™ improves sleep quality.
The Real World Evidence Study
29-day real-world study tracking 164 adults on TruCBN™: longer sleep, fewer wakings, better mornings.
The CBN Brain Study
Peer-reviewed preclinical study showing CBN improves memory and mitochondrial health in an accelerated aging model.
Request a Sample of TruCBN™
Free TruCBN™ sample shipped to qualified brands for formulation and testing.
Hemp in Medicare
Hemp in Medicare: The BEI Playbook
Step-by-step guide for hemp brands entering Medicare's new federal cannabinoid channel.
The TruCBN™ Medicare Memorandum
Clinical evaluation memo for ACOs assessing TruCBN™ under the CMS Substance Access BEI program.
Knowledge Center
Minor Cannabinoid Market Report
Sales data from 10 cannabis markets showing $132M in minor cannabinoid revenue and what's next.
THCV Simplified
Plain-English primer on THCV: science, formulation notes, and market potential for energy and focus products.
Featured
Hemp in Medicare: The BEI Playbook
Medicare opened its first federal channel for hemp-derived cannabinoid products in April 2026. This playbook walks hemp brands through what the BEI program is, what it takes to get a product accepted, and how TruCBN™ fits.
Get the Playbook
News
Contact Us
Technology
Academic Collaboration
Formulation Kit
Wholesale Ingredients
Retail Products
Wholesale Ingredients
Download the TruCBN™ Sleep Study
A randomized, placebo-controlled trial with over 1,000 participants showing how 50mg CBN significantly improved sleep quality compared to placebo.
